Skip to contentRedmile Group, LLC — ADC Therapeutics SA insider: 169 transactions · InsiderLensRedmile Group, LLC
- 10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
- Former 10% Owner and Director at Lifesci Acquisition II Corp. · on record since Mar 13, 2024
- Director at Atara Biotherapeutics, Inc. · on record since May 23, 2025
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
- Director at FATE THERAPEUTICS INC · on record since Apr 22, 2026
- 10% owner at FATE THERAPEUTICS INC · on record since Apr 22, 2026
- 10% owner at ARRAY BIOPHARMA INC · on record since Aug 28, 2015
- 10% owner at Attovia Therapeutics, Inc. · on record since Aug 4, 2026
- 10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
- 10% owner at AMICUS THERAPEUTICS INC · on record since Jun 13, 2016
- 10% owner at Xeris Biopharma Holdings, Inc. · on record since Jun 27, 2018
- Director at ALDER BIOPHARMACEUTICALS INC · on record since Apr 26, 2018
- 10% owner at Gritstone Oncology, Inc. · on record since Sep 27, 2018
- 10% owner at Replimune Group, Inc. · on record since Jul 25, 2018
- 10% owner at Allakos Inc. · on record since Jul 24, 2018
- 10% owner at VAPOTHERM INC · on record since Nov 16, 2018
- 10% owner at TCR2 THERAPEUTICS INC. · on record since Feb 21, 2019
- 10% owner at Akero Therapeutics, Inc. · on record since Jun 24, 2019
- 10% owner at · on record since Jun 24, 2019
- 10% owner at · on record since Jun 24, 2019
- Director at · on record since Sep 23, 2019
- 10% owner at · on record since Sep 23, 2019
- 10% owner at · on record since Oct 29, 2019
- 10% owner at · on record since Oct 8, 2019
- 10% owner at · on record since Feb 11, 2020
- 10% owner at · on record since Jun 25, 2020
- 10% owner at · on record since Jun 9, 2020
- 10% owner at · on record since Apr 6, 2020
- 10% owner at · on record since Jul 30, 2020
- 10% owner at · on record since Jul 30, 2020
- 10% owner at · on record since Jul 30, 2020
- 10% owner at · on record since Aug 25, 2020
- Director at · on record since Dec 28, 2020
- Director at · on record since Nov 27, 2020
- 10% owner at · on record since Nov 27, 2020
- Director at · on record since Oct 7, 2020
- 10% owner at · on record since Oct 7, 2020
- Director at · on record since Jul 28, 2021
- 10% owner at · on record since Jul 21, 2021
- 10% owner at · on record since Aug 12, 2021
- 10% owner at · on record since Oct 28, 2021
- Director at · on record since Oct 18, 2021
- 10% owner at · on record since Oct 18, 2021
- 10% owner at · on record since Oct 18, 2022
- 10% owner at · on record since Apr 24, 2019
- 10% owner at · on record since Apr 2, 2026
- 10% owner at · on record since Dec 28, 2020
Insider trading activity of Redmile Group, LLC
- Transactions on record
- 169
- since Aug 28, 2015
- Open-market buys
- 26
- $208.6M
- Open-market sells
- 9
- $23.2M
- Companies traded
- 27
- last filing Aug 7, 2026
Figures computed from official regulatory filings — .
Companies where Redmile Group, LLC has traded
- 4 tx · $10.2M · Aug 7, 2026
- 5 tx · Jul 24, 2026
- 16 tx · $102.5M · Jun 15, 2026
- 32 tx · $185.2M · Apr 2, 2026
- 6 tx · Jul 16, 2025
- 30 tx · $89.1M · Jul 2, 2025
- 4 tx · $7M · Jun 18, 2024
- 8 tx · $30M · Jun 14, 2024
- 6 tx · $39.9M · Jun 21, 2023
- 2 tx · $306.6K · Oct 18, 2022
- 1 tx · $125K · May 25, 2022
- 3 tx · $20M · Nov 4, 2021
- 3 tx · $25M · Aug 12, 2021
- 3 tx · $20M · Jun 23, 2021
Track record of Redmile Group, LLC
Statistical track record
Free- Open-market buys
- 51
- Last buy
- Aug 6, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Transaction history of Redmile Group, LLC
Co-insiders of Redmile Group, LLC
This page republishes public regulatory disclosures.
5 tx · $8.8M · Feb 16, 2021
| Company | Filed | Type | Qty | Price | Value · USD | Src | Details |
|---|
| Aug 7, 2026 | Other | 782,854 | — | — | SEC | |
| Aug 7, 2026 | Buy | 400,000 | 17.00 USD | $6.8M | SEC | |
| Aug 7, 2026 | OtherD (derivative) | -782,854 | — | — | SEC | |
| Aug 7, 2026 | Buy | 200,000 | 17.00 USD | $3.4M | SEC | |
| Jul 24, 2026 | Exercise | 195,211 | — | — | SEC | |
| Jul 24, 2026 | ExerciseD (derivative) | -38,735 | 0.00 USD | — | SEC | |
| Jul 24, 2026 | Other | -60 | — | — | SEC | |
| Jul 24, 2026 | ExerciseD (derivative) | -101,089 | 0.00 USD | — | SEC | |
| Jul 24, 2026 | ExerciseD (derivative) | -55,387 | 0.00 USD | — | SEC | |
| Jun 15, 2026 | AwardD (derivative) | 87,900 | 0.00 USD | — | SEC | |
| Apr 23, 2026 | OtherD (derivative) | -266,280 | 0.00 USD | — | SEC | |
| Apr 23, 2026 | OtherD (derivative) | 266,280 | 0.00 USD | — | SEC | |
| Apr 2, 2026 | Sell | -196,229 | 3.75 USD | $736.3K | SEC | |
| Apr 2, 2026 | Sell | -169,265 | 3.80 USD | $643K | SEC | |
| Apr 2, 2026 | Sell | -188,407 | 3.75 USD | $706.9K | SEC | |
| Apr 2, 2026 | Sell | -2,634,506 | 3.28 USD | $8.6M | SEC | |
| Apr 2, 2026 | Sell | -2,529,491 | 3.28 USD | $8.3M | SEC | |
| Apr 2, 2026 | Sell | -162,517 | 3.80 USD | $617.4K | SEC | |
| Jul 16, 2025 | AwardD (derivative) | 33,150 | 0.00 USD | — | SEC | |
| Jul 2, 2025 | Award | 828 | 0.00 USD | — | SEC | |
| Jun 13, 2025 | BuyD (derivative) | 12,465,234 | 3.43 USD | $42.8M | SEC | |
| Jun 13, 2025 | BuyD (derivative) | 15,734,267 | 3.43 USD | $54M | SEC | |
| May 30, 2025 | AwardD (derivative) | 55,000 | 0.00 USD | — | SEC | |
| Apr 2, 2025 | Award | 828 | 0.00 USD | — | SEC | |
| Jan 2, 2025 | Award | 1,734 | 0.00 USD | — | SEC | |